Biotransplant(BTRN) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotransplant(BTRN)

BTRN 35.35

0.0%

Nov 7 4:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: scaram(o)uche who wrote (1094)	11/10/2001 11:10:10 AM
From: scaram(o)uche	of 1475

>> Rich, would appreciate your comments on what this poster has said. << The second abstract, Spitzer et al............. Some patients, including some who never show symptoms of GVH, show prolonged disease-free survival following AlloMune. Lives are being extended or lost that would otherwise be lost. Beating dead horse...... In the past, I owned shares due to the XenoMune and 507 (MEDI) programs. My only near-term hopes were pinned on 507, and I've been bitterly disappointed in MEDI as a partner. Eligix brings a new near-term wrinkle, but I'm not yet a believer. I don't mind answering questions about AlloMune, but I've made it clear for some time that it does not fit into my investment reasoning.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next